Geratherm Medical AG / Key word(s): Final Results 23.03.2015 13:08 Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Ad hoc announcement pursuant to Section 15 WpHG Securities Trading Act, transmitted by DGAP - a company of EquityStory AG. The issuer is solely responsible for the content of this announcement. Geratherm Medical announces figures for 2014 - Significant increase in sales and earnings - Sales up by 11.2% to 18.7 million EUR - EBITDA up by 98.1% to 3,171K EUR; EBITDA margin 16.9% (2013: 9.5%) - EBIT up by 204.4% to 2,415K EUR; EBIT margin 12.9% (2013: 4.7%) - Profit from ordinary activities: up by 75.2% to 2,251K EUR - Profit attributable to shareholders (EAT) up by 26.1% to 1,682K EUR - Earnings per share: 34 cents (2013: 27 cents) - Proposed dividend: 25 cents per share (2013: 24 cents) - Segments: Healthcare Diagnostic: 12,156K EUR (-8.1%); EBIT 1,870K EUR Respiratory: 4,157K EUR (+98.4%); EBIT 203K EUR Medical Warming Systems: 1,860K EUR (+72.5%); EBIT: 227K EUR Cardio/Stroke: 542K EUR (+25.5%); EBIT -28K EUR Geschwenda, 23 March 2015 - At its meeting today, the Supervisory Board approved the financial statements and consolidated financial statements as of 31 December 2014. The financial statements are thus adopted. The Supervisory Board approved the Management Board's proposal for the use of retained earnings, which provides for a dividend of 25 cents per share. In 2014, Geratherm Medical generated its highest operating profit in terms of EBITDA of 3.2 million EUR. The overall performance of the company rose by 27.4% to 20.7 million EUR. The gross margin was 58.3%, up from 54.6% in 2013. High-quality medical technology products have led to significantly better results. The company's positive development is expected to continue in 2015. In Q1 2015, the company anticipates significant double-digit growth in both sales and earnings. The detailed annual report will be published on 23 April 2015. Short company profil: Geratherm Medical is an internationally operating medical products enterprise with the business areas Healthcare Diagnostic, Medical Warming Systems, Cardio/Stroke and Respiratory. Our company's roots are in temperature measurement in the medical sphere. In this business area we offer a broad spectrum of products, most of which have unique selling points. We supply our customers/patients with high-quality products ranging from thermometers to complex warming systems for use in the operating theatre and by emergency rescue services and MRI Diagnostic Incubator Systems for premature babies and newborns. In the Cardio business area we concentrate on the development of products for the detection of atrial fibrillation as a measure to prevent strokes. The Respiratory segment develops and markets products for the assessment of pulmonary function. In all mainly business areas, Geratherm has patent-protected basic technologies at its disposal. We regard ourselves as a research-based medical products company with a clear focus on medical diagnostic devices that generate vital data. Geratherm shares have been listed in the Prime Standard segment of the Frankfurt Stock Exchange since the year 2000. Geratherm Medical continues to be represented in the German Entrepreneurial Index and in the German Healthcare Index. Geratherm Medical AG, Investor Relations Fahrenheitstraße 1, 98716 Geschwenda Tel. +49 (0)36205/98 111, E-Mail: [email protected] www.geratherm.com Emittent: Geratherm Medical AG, Fahrenheitstraße 1, 98716 Geschwenda Deutschland Tel. 036205/98 111 Fax: 036205/98 115 ISIN : DE 000 549 562 6 WKN : 549 562 Börsen : Frankfurter Wertpapierbörse /Geregelter Markt/Prime Standard Börse: Freiverkehr in Berlin-Bremen, Düsseldorf, Hamburg, München, Stuttgart Ende der Mitteilung 23.03.2015 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: Geratherm Medical AG Fahrenheitstraße 1 98716 Geschwenda Germany Phone: +49 (0)36205 98-0 Fax: +49 (0)36205 98-1 15 E-mail: [email protected] Internet: www.geratherm.com ISIN: DE0005495626 WKN: 549562 Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart End of Announcement DGAP News-Service ---------------------------------------------------------------------------